Invitae Completes $40M Series E Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic diagnostics firm Invitae today announced it completed a Series E financing round that raised $40 million.

The funds will go toward further development of the San Francisco-based company's clinical genetic tests for hereditary disorders, including oncology, cardiology, neurology, and pediatric medicine, it said, adding that it plans to expand into international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.